American Society of Hematology

2018 ASH Meeting on Lymphoma Biology

August 2-5, 2018
Washington, DC


The goal of the meeting is to further the understanding of lymphoma pathogenesis and accelerate new therapies by providing a forum for scientific exchange. The four-day meeting consists of didactic sessions, abstract presentations, and interactive workshops/panel discussions. The target audience for this meeting includes laboratory-based scientists, translational investigators, pharmaceutical scientists, and others interested in lymphoma science.

Program Co-Chairs

  • Riccardo Dalla-Favera, MD
    Columbia University, New York, NY
  • Kojo Elenitoba-Johnson, MD
    University of Pennsylvania, Philadelphia, PA
  • Freda Stevenson, Dphil
    University of Southampton Medical School, Southampton, UK

Steering Committee Members

  • John Byrd, MD, The Ohio State University, Columbus, OH
  • Elias Campo, MD, PhD, Hospital Clinic, Barcelona, Spain
  • Ralf Kuppers, PhD, University of Duisburg-Essen, Essen, Germany
  • Ron Levy, MD, Stanford University, Stanford, CA
  • Greg Nowakowski, MD, Mayo Clinic, Rochestern, MN
  • Margaret Shipp , MD, Dana-Farber Cancer Institute, Boston, MA
  • Louis Staudt, MD, PhD, NCI, NIH, Bethesda, MD
  • Catherine Wu, MD, Dana-Farber Cancer Institute, Boston, MA

Past Meeting Resources

Questions

For more information about abstracts and speakers, please contact ASHMLB@hematology.org.

For information about corporate support, please contact development@hematology.org.

Please submit all general inquiries to meetings@hematology.org.

Related Item

back to top